MedTrace Logo

Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera

NCT05566626 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-10-21

No results posted yet for this study

Summary

An explorative study of the Mantis Photonics hyperspectral camera for retinal imaging and estimation of retinal oxygenation.

Primary objective: To evaluate the performance of the hyperspectral camera for non-invasive retinal examination in order to improve the diagnosis of diseases affecting the retina or central nervous system. Secondary objective: To investigate the possibilities of the use of a hyperspectral camera for non-invasive retinal examination.

Conditions

  • Glaucoma Eye
  • Macular Degeneration
  • Macula Abnormality
  • Retinal Detachment

Interventions

DEVICE

Hyperspectral retinal image

Hyperspectral image of both eyes

DRUG

Mydriacyl Ophthalmic Product

Mydriatic drops before retinoscopy

Sponsors & Collaborators

  • Sundets Ögonläkare

    collaborator UNKNOWN

  • Mantis Photonics AB

    lead INDUSTRY

Principal Investigators

  • Madeleine Selvander, MD · Sundets Ögonläkare

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2023-11-30
Completion
2023-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05566626 on ClinicalTrials.gov